CoChat

Comparing 18 F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease

Open access
Mattsson, Niklas, Smith, Ruben, Strandberg, Olof, Palmqvist, Sebastian, Schöll, Michael, Insel, Philip S., Hägerström, Douglas, Ohlsson, Tomas, Zetterberg, Henrik, Blennow, Kaj, Jögi, Jonas, Hansson, Oskar · 2018 · Neurology
Cited by 95

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Abstract

Objective To compare PET imaging of tau pathology with CSF measurements (total tau [t-tau] and phosphorylated tau [p-tau]) in terms of diagnostic performance for Alzheimer disease (AD). Methods We compared t-tau and p-tau and 18F-AV-1451 in 30 controls, 14 patients with prodromal AD, and 39 patients with Alzheimer dementia, recruited from the Swedish BioFINDER study. All patients with AD (prodromal and dementia) were screened for amyloid positivity using CSF β-amyloid 42. Retention of 18F-AV-1451 was measured in a priori specified regions, selected for known associations with tau pathology in AD. Results Retention of 18F-AV-1451 was markedly elevated in Alzheimer dementia and moderately elevated in prodromal AD. CSF t-tau and p-tau was increased to similar levels in both AD dementia and prodromal AD. 18F-AV-1451 had very good diagnostic performance for Alzheimer dementia (area under the receiver operating characteristic curve [AUROC] ∼1.000), and was significantly better than t-tau (0.876), p-tau (0.890), hippocampal volume (0.824), and temporal cortical thickness (0.860). For prodromal AD, there were no significant AUROC differences between CSF tau and 18F-AV-1451 measures (0.836–0.939), but MRI measures had lower AUROCs (0.652–0.769). Conclusions CSF tau and 18F-AV-1451 have equal performance in early clinical stages of AD, but 18F-AV-1451 is superior in the dementia stage, and exhibits close to perfect diagnostic performance for mild to moderate AD. Classification of evidence This study provides Class III evidence that CSF tau and 18F-AV-1451 PET have similar performance in identifying early AD, and that 18F-AV-1451 PET is superior to CSF tau in identifying mild to moderate AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0000000000004887

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Cited by

See all 95

Metadata

Authors
Mattsson, N., Smith, R., Strandberg, O., Palmqvist, S., Schöll, M., Insel, P. S., Hägerström, D., Ohlsson, T., Zetterberg, H., Blennow, K., Jögi, J., & Hansson, O.
Venue
Neurology
Published
2018-01-30
Volume
90
Issue
5
Pages
e388-e395
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2784286559
Cited by
95
References
22
FWCI
10.75
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparing 18 F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease. https://app.cochat.ai/papers/10.1212/wnl.0000000000004887
The paper
Mattsson, N., Smith, R., Strandberg, O., Palmqvist, S., Schöll, M., Insel, P. S., Hägerström, D., Ohlsson, T., Zetterberg, H., Blennow, K., Jögi, J., & Hansson, O. (2018). Comparing 18 F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease. Neurology. https://doi.org/10.1212/wnl.0000000000004887

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.